Effect of Lutein, Zeaxanthin, and Meso-Zeaxanthin Supplementation on Skin Carotenoid Concentration: A Six-Month, Placebo-Controlled Crossover Study
NCT ID: NCT06965426
Last Updated: 2025-09-24
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
60 participants
INTERVENTIONAL
2025-06-01
2026-12-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Macular Pigment and Glare Disability
NCT00909090
Effects of Lutein and Zeaxanthin Supplementation on Early Age-related Macular Degeneration
NCT01528605
Lutein for Age-Related Macular Degeneration
NCT00006202
Effects of Lutein and Zeaxanthin Supplementation on Age-related Macular Degeneration
NCT01048476
The Zeaxanthin and Visual Function Study
NCT00564902
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
PREVENTION
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
MacuHealth Supplementation
Lutein, Zeaxanthin, and Meso-Zeaxanthin Supplementation
Lutein, Zeaxanthin, and Meso-Zeaxanthin Supplementation
Lutein, Zeaxanthin, and Meso-Zeaxanthin Supplementation
Placebo
Placebo
Lutein, Zeaxanthin, and Meso-Zeaxanthin Supplementation
Lutein, Zeaxanthin, and Meso-Zeaxanthin Supplementation
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Lutein, Zeaxanthin, and Meso-Zeaxanthin Supplementation
Lutein, Zeaxanthin, and Meso-Zeaxanthin Supplementation
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Willing to comply with the protocol instructions.
* Has read (or has had read to), understood, and signed an Informed Consent.
Exclusion Criteria
* Pregnant, plan to become pregnant or breastfeeding
* History of any non-controlled disease states including diabetes, cancer, heart diseases ETC (we need to confirm this with previous protocols) BMI greater than 30
* Currently taking MacuHealth or similar supplements or previous use
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
MacuHealth
INDUSTRY
Insight Eyecare Specialties, Inc. dba Vision Source Eyecare,
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Vision Source
Kansas City, Missouri, United States
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
VSE001
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.